Review
Open access
Sep 2026
Integrating artificial intelligence across the cancer drug discovery pipeline using a design-test-refine workflow
Robust validation across increasingly complex cancer models is required and it is proposed that AIDD should be used to prioritize testable treatment predictions, to form a holistic design-test-refine workflow.
Jin-Ming Bai, Jessica Sarah Faure, Tawfeeq Ahmed Khalfe et al.
· Frontiers in Oncology · 0 citations